Schedule 13G ownership disclosure

Bambusa Therapeutics, Inc.

Common Stock, par value $0.00001 per share · CUSIP: 058937103

Event date: 2026-10-29

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • ATHOS KG

    Shares: 4,579,067.00 · Class: 9.0%

  • Objektgesellschaft Salzufer 1 GmbH

    Shares: 4,579,067.00 · Class: 9.0%

  • Salzufer Holding Inc.

    Shares: 4,579,067.00 · Class: 9.0%

  • Thomas Maier

    Shares: 4,699,188.00 · Class: 9.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002085929-26-000014
Form type
SCHEDULE 13G
Filer
Bambusa Therapeutics, Inc.
CIK
CIK 2044950
Filed
Nov 05, 2026
Reporting period
Oct 29, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub